Portage, MI, United States of America

Kjell Anders Ivan Svensson

This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Pharmacia & Upjohn Company, Eli Lilly and Company. Active years: 2002-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kjell Anders Ivan Svensson. Retrieved from https://idiyas.com/inventor/kjell-anders-ivan-svensson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 33.3

 

 

Average Co-Inventor Count = 4.8

ph-index = 1


Company Filing History:


Years Active: 2002-2026

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Introduction

Kjell Anders Ivan Svensson is an accomplished inventor based in Portage, MI, known for his significant contributions in the pharmaceutical field. With a focus on innovative processes, Svensson has developed unique compounds that have the potential to advance medical science.

Latest Patents

Kjell has been granted two patents, the latest of which involves a novel process to prepare 2-aminoindan derivatives. This invention specifically targets (2S)-enantiomers of 2-aminoindan derivatives, showcasing his expertise in the area of chemical synthesis and pharmaceutical applications.

Career Highlights

Svensson currently works at Pharmacia & Upjohn Company, where he applies his knowledge and skills in drug development. His career has been marked by his commitment to advancing pharmaceutical innovations, contributing to the company's mission of improving healthcare outcomes.

Collaborations

Throughout his career, Kjell has collaborated with notable colleagues, including Arthur Glenn Romero and Thomas Andrew Runge. Their combined expertise has fostered a creative and productive environment, leading to advancements in their respective fields.

Conclusion

Kjell Anders Ivan Svensson is a notable inventor whose work in pharmaceutical processes reflects his dedication to innovation. With patents that highlight his ability to develop new compounds, he continues to make significant strides within the industry. His collaborations and contributions are sure to impact the future of pharmaceutical research and development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…